IFNG and Alzheimer disease: Moreover, PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer’s disease by evoking an IFN-γ-dependent systemic immune response, which is followed by the recruitment of macrophages to the brain19.